HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of prostratin on T-cell activation and human immunodeficiency virus latency.

Abstract
Human immunodeficiency virus (HIV) replication is linked to cellular gene transcription and requires target cell activation. The latent reservoir of HIV-1 in quiescent T cells is thought to be a major obstacle to clearance of infection by highly active antiretroviral therapy (HAART). Thus, identification of agents that can induce expression of latent virus may, in the presence of HAART, allow elimination of the infected cells by the immune response. We previously used the SCID-hu (Thy/Liv) mouse model to establish that activation-inducible HIV can be generated at high frequency during thymopoiesis. Latently infected mature thymocytes can be exported into the periphery, providing an efficient primary cell model to determine cellular activation signals that induce renewed expression of latent virus. Here we characterized the effects of prostratin, a non-tumor-promoting phorbol ester, on primary human peripheral blood lymphocytes (PBLs) and assessed its ability to reactivate latent HIV infection from thymocytes and PBLs in the SCID-hu (Thy/Liv) model. Prostratin stimulation alone did not induce proliferation of quiescent PBLs; however, it could provide a secondary signal in the context of T-cell receptor stimulation or a primary activation signal in the presence of CD28 stimulation to induce T-cell proliferation. While prostratin alone was not sufficient to allow de novo HIV infection, it efficiently reactivated HIV expression from latently infected cells generated in the SCID-hu mouse. Our data indicate that prostratin alone is able to specifically reactivate latent virus in the absence of cellular proliferation, making it an attractive candidate for further study as an adjunctive therapy for the elimination of the latent HIV reservoir.
AuthorsYael D Korin, David G Brooks, Stephen Brown, Andrew Korotzer, Jerome A Zack
JournalJournal of virology (J Virol) Vol. 76 Issue 16 Pg. 8118-23 (Aug 2002) ISSN: 0022-538X [Print] United States
PMID12134017 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • CD69 antigen
  • Lectins, C-Type
  • Phorbol Esters
  • Receptors, Interleukin-2
  • prostratin
Topics
  • Animals
  • Antigens, CD (metabolism)
  • Antigens, Differentiation, T-Lymphocyte (metabolism)
  • Cell Cycle (drug effects)
  • Disease Models, Animal
  • HIV Infections (drug therapy, immunology, virology)
  • HIV-1 (drug effects, physiology)
  • Humans
  • In Vitro Techniques
  • Lectins, C-Type
  • Lymphocyte Activation (drug effects)
  • Mice
  • Mice, SCID
  • Phorbol Esters (pharmacology)
  • Receptors, Interleukin-2 (metabolism)
  • T-Lymphocytes (cytology, drug effects, immunology, virology)
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: